Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Endokrinologikum Hamburg

Verified siteinfo

Germany Lornsenstraße 6, 63225 Hamburg, Germany

  • 1 trial recruiting
  • Obesity · Overweight
  • Adult patients

About Specializations

Endokrinologikum Hamburg in Hamburg, Germany specialises in clinical trials of conditions such as Obesity, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases

At Endokrinologikum Hamburg, the clinical trial activity focuses on nutritional and metabolic diseases, with a strong emphasis on chronic weight management. The studies are designed to evaluate whether a new therapy can help reduce body weight more effectively than placebo in adults living with obesity or overweight.

  • Research in obesity and overweight in adults
  • Assessment of treatment effectiveness for body weight reduction
  • Clinical evaluation in people with and without type 2 diabetes mellitus

These trials aim to improve care for patients seeking better long-term weight control, while also contributing to the broader understanding of therapies for metabolic health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Lornsenstraße 663225 HamburgGermany
Open in maps ↗
Recruiting now
1 trial
Conditions studied
2
Partner status
Verified site

More sites in HamburgGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Obesity+1

Recruiting

Phase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity+1

Not recruiting

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity+1

Not recruiting

Study on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.